Etomoxir
- Level
- Commodity
- Parent
- 51121900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51121919This classification denotes an enzyme inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MSB3DD2XP6. European Medicines Agency schedules Etomoxir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07332MIG. Etomoxir generally arises in the molecular formula C17H23CLO4. The term ETOMOXIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, no. 5, 1985, list 25.) Most nations schedule etomoxir under HS 29189900 and SITC 51396. As of Q4 2014, ETOMOXIR remains the US FDA Preferred Term for this commodity. Etomoxir bears US NLM identifiers UMLS ID C0059872 and NCI Concept Code C81111. SMILES: CLC1CCC(OCCCCCCC2(OC2)C(=O)OCC)CC1.
Same parent
Under 51121900 · 19Activities that produce or sell this
KBLI · 8Inherited from family 51120000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.